Tizanidine
Product Images NDC 50436-6756

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-6756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

This is a table showing plasma Tzanidine concentration (ng/mL) at different hours after dosing with Taanidine tablets/capsules. The table includes dosing instructions with or without food. There is no additional information available.*

FDA Label Image

Fig2 (Fig2)

The text seems to be an incomplete graph or chart, showing the "Improvement in Ashworth Score" after the administration of either 16 mg tizanidine or placebo. It also includes a time variable labeled "Hours Post-Dose." However, without additional information or context, it is difficult to determine the full significance or implications of this data.*

FDA Label Image

Fig3 (Fig3)

This text provides information about a study that evaluated the improvement in Ashworth Score using zanidine with a mean dose of 28.6mg. The study observed the endpoint at the end of maintenance at study week 7 using the Last Observation carried Forward method.*

FDA Label Image

Label Image (Lbl504366756)

This is a description of medication Tizanidine Hydrochloride 4 mg/30 tablets used for relief of muscle spasms. The NDC number is 5043667561 and there is information about the manufacturer and expiration date. The medication should be stored at room temperature and the package insert should be consulted for dosage information. It is a prescription drug.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.